相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
Kyle D. Konze et al.
ACS CHEMICAL BIOLOGY (2013)
Convergent evolution of chromatin modification by structurally distinct enzymes: comparative enzymology of histone H3 Ly27 methylation by human polycomb repressive complex 2 and vSET
Brooke M. Swalm et al.
BIOCHEMICAL JOURNAL (2013)
Multifaceted role of EZH2 in breast and prostate tumorigenesis: Epigenetics and beyond
Gauri Deb et al.
EPIGENETICS (2013)
Epigenetic regulation of estrogen signaling in breast cancer
Eric Hervouet et al.
EPIGENETICS (2013)
EZH2 Promotes E2F-Driven SCLC Tumorigenesis through Modulation of Apoptosis and Cell-Cycle Regulation
Roland Hubaux et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity
X. Zhao et al.
LEUKEMIA (2013)
Inner workings and regulatory inputs that control Polycomb repressive complex 2
M. Maggie O'Meara et al.
CHROMOSOMA (2012)
Cooperation between Polycomb and androgen receptor during oncogenic transformation
Jonathan C. Zhao et al.
GENOME RESEARCH (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
Michael T. McCabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
Wei Qi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
Molecular architecture of human polycomb repressive complex 2
Claudio Ciferri et al.
ELIFE (2012)
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
Damian B. Yap et al.
BLOOD (2011)
Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer
Qi Cao et al.
CANCER CELL (2011)
Histone Methyltransferase EZH2 Induces Akt-Dependent Genomic Instability and BRCA1 Inhibition in Breast Cancer
Maria E. Gonzalez et al.
CANCER RESEARCH (2011)
Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage
Z. Wu et al.
CELL DEATH AND DIFFERENTIATION (2011)
Insights into Association of the NuRD Complex with FOG-1 from the Crystal Structure of an RbAp48.FOG-1 Complex
Sara Lejon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
Shuet Theng Lee et al.
MOLECULAR CELL (2011)
Histone Methylation by PRC2 Is Inhibited by Active Chromatin Marks
Frank W. Schmitges et al.
MOLECULAR CELL (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis
Irina Velichutina et al.
BLOOD (2010)
Androgens Suppress EZH2 Expression Via Retinoblastoma (RB) and p130-Dependent Pathways: A Potential Mechanism of Androgen-Refractory Progression of Prostate Cancer
Laura R. Bohrer et al.
ENDOCRINOLOGY (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Structural Biology of Human H3K9 Methyltransferases
Hong Wu et al.
PLOS ONE (2010)
Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2)
Chao Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Dimerization of a viral SET protein endows its function
Hua Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
Christopher J. Sneeringer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Chemical mechanisms of histone lysine and arginine modifications
Brian C. Smith et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2009)
Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
Feng Sun et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Role of the polycomb protein EED in the propagation of repressive histone marks
Raphael Margueron et al.
NATURE (2009)
Protein methyltransferases as a target class for drug discovery
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
Yanqi Chang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Jeffrey A. Simon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Enzymatic mechanism and product specificity of SET-domain protein lysine methyltransferases
Xiaodong Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Molecular and functional mapping of EED motifs required for PRC2-Dependent histone methylation
Nathan D. Montgomery et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome
Jindan Yu et al.
CANCER RESEARCH (2007)
Structural basis of EZH2 recognition by EED
Zhifu Han et al.
STRUCTURE (2007)
Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells
Bin Shi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
The N terminus of Drosophila ESC binds directly to histone H3 and is required for E(Z)-dependent trimethylation of H3 lysine 27
Feng Tie et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase
Stefan Kubicek et al.
MOLECULAR CELL (2007)
Catalytic roles for carbon-oxygen hydrogen bonding in SET domain lysine methyltransferases
Jean-Francois Couture et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structural insights of the specificity and catalysis of a viral histone H3 lysine 27 methyltransferase
Chengmin Qian et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Subunit contributions to histone methyltransferase, activities of fly and worm Polycomb group complexes
CS Ketel et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
D Greiner et al.
NATURE CHEMICAL BIOLOGY (2005)
The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation
ND Montgomery et al.
CURRENT BIOLOGY (2005)
Nucleosome binding and histone methyltransferase activity of Drosophila PRC2
M Nekrasov et al.
EMBO REPORTS (2005)
In vitro and in vivo analyses of a Phe/Tyr switch controlling product specificity of histone lysine methyltransferases
RE Collins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Different Ezh2-containing complexes target methylation of histone H1 or nucleosomal histone H3
A Kuzmichev et al.
MOLECULAR CELL (2004)
Polycomb group suppressor of zeste 12 links heterochromatin protein 1α and enhancer of zeste 2
K Yamamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex
R Cao et al.
MOLECULAR CELL (2004)
Role of histone H2A ubiquitination in polycomb silencing
HB Wang et al.
NATURE (2004)
Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity
D Pasini et al.
EMBO JOURNAL (2004)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structural basis for the product specificity of histone lysine methyltransferases
X Zhang et al.
MOLECULAR CELL (2003)
Structure and catalytic mechanism of the human histone methyltransferase SET7/9
B Xiao et al.
NATURE (2003)
SET domains and histone methylation
B Xiao et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2003)
Role of histone H3 lysine 27 methylation in polycomb-group silencing
R Cao et al.
SCIENCE (2002)
Structure of the SET domain histone lysine methyltransferase Clr4
JR Min et al.
NATURE STRUCTURAL BIOLOGY (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Structure of the neurospora SET domain protein DIM-5, a histone H3 lysine methyltransferase
X Zhang et al.
CELL (2002)
Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma
FJ van Kemenade et al.
BLOOD (2001)
Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor
M Bray et al.
ANTIVIRAL RESEARCH (2000)
分享论文
